EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prenatal Exome Sequencing: When Does Diagnostic Yield Meet Clinical Utility?

Alessia Carrer iD, Francesco Maria Crupano, Berardo Rinaldi iD, Giulietta Scuvera, Claudia Cesaretti iD, Valeria Nicotra, Silvana Gangi, Lorenzo Colombo, Gabriella Araimo, Matilde Tagliabue iD, Daniela Marchetti, Laura Pezzoli iD und 10 weitere

Genes · 2025

DOI: 10.3390/genes17010037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Alessia Carrer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, 20122 Milan, Italy. Hauptthemen laut MEDLINE: Exome Sequencing, Prenatal Diagnosis, Congenital Abnormalities. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Prenatal Exome Sequencing (pES) has revolutionized prenatal diagnosis in fetuses with congenital anomalies. Although its performance is very promising, previous pES studies have mainly focused on diagnostic yield, often without considering the actual impact on ongoing pregnancies. In this study, we aim to (1) assess whether a prenatal molecular diagnosis can reliably predict the clinical features of the unborn child and (2) determine the gestational age (gw) at which ultrasound (US) findings are sufficient to support the pathogenicity of genetic variants detected by pES.

Methods

We retrospectively selected 47 cases complicated by US anomalies that underwent Exome Sequencing (ES) and for which complete clinical assessment was available. A blinded reanalysis of ES data was performed, considering only prenatal features.

Results

In our cohort, standard ES led to a molecular diagnosis in 43% of cases. The blinded reanalysis revealed that a complete or partial retrospective prenatal diagnosis was achievable in 95% of diagnosed cases. The mean gestational week at which US data would have supported molecular diagnosis was 22 + 5 weeks. The clinical follow-up confirmed a syndromic presentation in 21 out of 23 newborns and in all terminated pregnancies.

Conclusions

Our study further confirms that pES is a valuable diagnostic tool for detecting genetic etiology in fetuses with congenital malformations. In most cases, pES results accurately predict the postnatal phenotype. However, the prenatal setting requires specific adjustments and precautions, and a negative pES result cannot be considered reassuring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingPrenatal DiagnosisCongenital AbnormalitiesHumansFemalePregnancyRetrospective StudiesGestational AgeUltrasonography, PrenatalGenetic TestingAdult

Stichwörter der Autor:innen

clinical utilitydiagnostic yieldfetal anomaliesgenotype-phenotype correlationprenatal exome sequencing

Autor:innen und Institutionen

  • Department of Health Sciences, University of Milan, 20122 Milan, Italy.
  • Medical Genetics Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Fetal Medicine and Surgery Service, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Neonatal Intensive Care Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
  • Medical Genetics Laboratory, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

ORCID-Profile: Alessia Carrer, Berardo Rinaldi, Claudia Cesaretti, Matilde Tagliabue, Laura Pezzoli, Simona Boito, Maria Francesca Bedeschi, Federica Natacci

Förderung

  • Italian Ministry of Health

Zitieren

APA

Carrer, A., Crupano, F. M., Rinaldi, B., Scuvera, G., Cesaretti, C., Nicotra, V., Gangi, S., Colombo, L., Araimo, G., Tagliabue, M., Marchetti, D., Pezzoli, L., Garzo, M., Accurti, V., Volpe, G., Boito, S., Finelli, P., Fumagalli, M., Bedeschi, M. F., …, & Natacci, F. (2025). Prenatal Exome Sequencing: When Does Diagnostic Yield Meet Clinical Utility?. Genes. https://doi.org/10.3390/genes17010037

Vancouver

Carrer A, Crupano FM, Rinaldi B, Scuvera G, Cesaretti C, Nicotra V, et al. Prenatal Exome Sequencing: When Does Diagnostic Yield Meet Clinical Utility?. Genes. 2025. doi:10.3390/genes17010037

BibTeX
@article{Carrer2025,
  author = {Carrer, Alessia and Crupano, Francesco Maria and Rinaldi, Berardo and Scuvera, Giulietta and Cesaretti, Claudia and Nicotra, Valeria and Gangi, Silvana and Colombo, Lorenzo and Araimo, Gabriella and Tagliabue, Matilde and Marchetti, Daniela and Pezzoli, Laura and Garzo, Maria and Accurti, Veronica and Volpe, Grazia and Boito, Simona and Finelli, Palma and Fumagalli, Monica and Bedeschi, Maria Francesca and Iascone, Maria and Persico, Nicola and Natacci, Federica},
  title = {Prenatal Exome Sequencing: When Does Diagnostic Yield Meet Clinical Utility?},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes17010037}
}
Kostenlos starten →